Sign up for free newsletter

 

FSA approves Xtrakter for regulatory reporting of derivatives

FSA approves Xtrakter for regulatory reporting of derivatives


The UK Financial Services Authority has approved Xtrakter to regulatory report exchange-traded derivatives using alternative instrument identifiers.

The approval was awarded to Xtrakter after it successfully completed an FSA review and a period of extensive testing.

As an approved reporting mechanism) Xtrakter will continue to adhere to the requirements of Directive 2004/39/EC of the European Parliament and of the Council 21, April 2004 Markets in Financial Instruments Directive.

Yannic Weber, chief executive officer of Xtrakter, says: “We are pleased to have obtained FSA approval for our new Aii reporting service. This endorsement reinforces our position as a regulatory reporting hub for European transactions. Xtrakter delivered its new Aii reporting functionality on time and we are already processing complex derivative reports. I would like to take this opportunity to thank all those who were involved in making this possible.”

Xtrakter provides regulatory reporting to the FSA (UK), AMF (France) and AFM (Netherlands). Xtrakter additionally provides primary dealers with an onward reporting facility to the National Bank of Belgium in accordance with the NBB and Securities Regulation Fund requirements.

events
3 days 11 hours from now - London
4 days 11 hours from now - London
4 days 11 hours from now - New York
5 days 4 hours from now - London
listingsdirectory
Maitland
Thu, 29/09/2016 - 21:25
Meyler Capital
Tue, 06/09/2016 - 15:57
Nasdaq
Tue, 30/08/2016 - 11:02
training
Mon, 03/10/2016   - London
Mon, 03/10/2016   - London
Tue, 04/10/2016   - London
specialreports
other gfm publications